Exelixis EXEL Total costs & expenses

Total costs & expenses at other companies

Opko HealthOPK

$170.55M-21.3%

Jazz PharmaceuticalsJAZZ

$732.3M-23.2%

IncyteINCY

$976.14M+42.5%

Gilead SciencesGILD

$18.2B+295%

United TherapeuticsUTHR

$452.5M+4.2%

Kura OncologyKURA

——

FAQ

What is Exelixis's total costs & expenses?

Exelixis (EXEL) reported total costs & expenses of $380.28M in Q2 2026.

How has Exelixis's total costs & expenses changed year-over-year?

Exelixis's total costs & expenses increased by 7.2% year-over-year, from $354.69M to $380.28M.

What is the long-term trend for Exelixis's total costs & expenses?

Over 4 years (2021 to 2025), Exelixis's total costs & expenses has grown at a 6.0% compound annual growth rate (CAGR), from $1.15B to $1.45B.

What does total costs & expenses mean?

Total costs and expenses represent the aggregate of all operating and non-operating costs incurred by the company during a period. This metric provides a comprehensive view of the company's total burn rate and operational footprint.